HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Califf Lowering FDA Drawbridge To Work With External Expertise

This article was originally published in The Tan Sheet & The Rose Sheet

Executive Summary

In Pink Sheet's exclusive interview, new commissioner says FDA will tap knowledge beyond its walls, without compromising agency independence.

You may also be interested in...



Don't Rush To Reorganize FDA, McClellan Says

Former commissioner says agency has to think about getting biggest bang for the buck when considering a reorganization to disease-focused teams.

FDA Talent Hunt: Is Recruiting From Academia Better Than Industry?

CDER Oncology office head Richard Pazdur says making FDA more academic could help with retention.

Califf Supports Combo Products Pathway At Confirmation Hearing

FDA's concepts for new pathway could be ready for congressional scrutiny within a year.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS133910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel